India’s oncology tests market to grow at 2% CAGR through 2033: Report [Video]

The oncology test market in India is expected to grow at a compound annual growth rate (CAGR) of around 2 per cent through 2033, according to a report on Friday.

The report by GlobalData, a data and analytics company, showed that the rise in cancers in the country is primarily due to lifestyle changes, environmental factors, and an ageing population.

Cancer poses a significant social and healthcare burden in India, creating a rising demand for advanced oncology diagnostic and treatment services. More than 1 Million new cases are diagnosed annually and around 900,000 deaths are recorded per year.

In 2024, India accounted for over 3 per cent of the Asia-Pacific (APAC) oncology tests market, the research reveals.

But, by accelerating efforts to develop innovative solutions and support cutting-edge research, the country aspires to increasingly address the healthcare needs of both its own population and global communities.

“Oncology tests in India face several challenges related to access, affordability, and technological adoption. Because …